| Inflawell(®) improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial 2022 · Inflawell® intervention group (BAs group) · Adults aged 18 years or older hospitalized with PCR-positive moderate COVID-19 | 999 mg | 2 weeks | 25 |
| Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery 2025 · Group B: CBB + placebo · Women aged over 18 with breast cancer undergoing breast-conserving surgery | 200 mg | 30 days | 37 |
| Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects 2022 · CASP supplement group · Male and female adults aged 18–70 with mild-to-moderate acute diarrhea | 500 mg | 5 days | 24 |
| Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study 1998 · Boswellia serrata gum resin group · Adults aged 18–75 with bronchial asthma | 900 mg | 6 weeks | 40 |
| A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee 2011 · Aflapin group · Adults aged 40–80 of either sex with mild to moderate unilateral or bilateral knee osteoarthritis | 100 mg | 30 days | 30 |
| A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee 2008 · 5-Loxin low-dose group (100 mg/day) · Men and women aged 40–80 years with knee osteoarthritis | 100 mg | 90 days | 24 |
| A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee 2019 · BSE group (XAXA01) · Men and women aged 35–75 with newly diagnosed or untreated mild-to-moderate knee osteoarthritis | 339 mg | 120 days | 24 |
| A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee 2008 · 5-Loxin high-dose group (250 mg/day) · Men and women aged 40–80 years with knee osteoarthritis | 250 mg | 90 days | 23 |
| Effects of gum resin of Boswellia serrata in patients with chronic colitis 2001 · Boswellia gum resin · 18- to 48-year-old men and women with chronic colitis | 900 mg | 6 weeks | 20 |
| Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study 2010 · 5-Loxin group · Adults aged 40 years or older with diagnosed knee osteoarthritis | 100 mg | 90 days | 20 |
| Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study 2010 · Aflapin group · Adults aged 40 years or older with diagnosed knee osteoarthritis | 100 mg | 90 days | 20 |
| A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (Curcuma longa), Boswellia (Boswellia serrata), and French Maritime Pine Bark (Pinus pinaster) 2021 · lower-dose boswellia · Men aged 47–65 with Gulf War Illness | 400 mg | 30 days | 10 |
| A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (Curcuma longa), Boswellia (Boswellia serrata), and French Maritime Pine Bark (Pinus pinaster) 2021 · higher-dose boswellia · Men aged 47–65 with Gulf War Illness | 800 mg | 30 days | 10 |
| Functional study on Boswellia phytosome as complementary intervention in asthmatic patients 2015 · Casperome® · Asthmatic subjects receiving standard inhaled corticosteroid and long-acting beta-agonist treatment | 500 mg | 4 weeks | — |
| The effect of frankincense (Boswellia serrata, oleoresin) and ginger (Zingiber officinale, rhizoma) on heavy menstrual bleeding: A randomized, placebo-controlled, clinical trial 2019 · frankincense group · Women of reproductive age with heavy menstrual bleeding | 900 mg | 2 weeks | — |
| A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study 2025 · SN13108F-supplemented subjects · Adult men and women with Kellgren-Lawrence grade II–III knee osteoarthritis | 100 mg | 180 days | — |
| Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery 2025 · Group A: CBB + neurotrophic agents · Women aged over 18 with breast cancer undergoing breast-conserving surgery | 200 mg | 30 days | 39 |
| Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study 2018 · Curamin · Men and women aged 40–77 with degenerative hypertrophic knee osteoarthritis | 450 mg | 12 weeks | 67 |
| Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis 2022 · supplemented group · men and women aged 18–70 with irritable bowel syndrome, small bowel dysbiosis, and abdominal bloating | 1 g | 30 days | 33 |
| Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis 2017 · Group B · Adults aged 40–70 with early knee osteoarthritis | 100 mg | 40 days | 30 |
| Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial 2025 · Nutraceutical group · Adult women and men aged 40–65 with mild-to-moderate knee osteoarthritis | 600 mg | 90 days | 30 |
| A Nutraceutical Combination of Bromelain and Boswellia Serrata Casperome® in Siben®: Effects on the Postoperative Course of Inguinal Hernioplasty with Mesh at One Year Follow up. A Randomized Multicentric Study 2024 · study group · Adults undergoing open inguinal hernioplasty with mesh; age and sex details for this arm not reported | 400 mg | 11 days | — |
| Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study 2022 · TBF (Rhuleave-K) · Healthy men and women aged 18–65 with exercise-induced acute musculoskeletal pain | 10 mg | 1 day | 116 |
| Determination of major boswellic acids in plasma by high-pressure liquid chromatography/mass spectrometry 2011 · BSE group · Patients with primary or secondary brain tumors and associated peritumoral edema; age and sex not reported | 4.2 g | — | 14 |
| Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers 2004 · Treatment A (fasted state) · Healthy male subjects | 786 mg | 1 day | — |
| Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers 2004 · Treatment B (with high-fat meal) · Healthy male subjects | 786 mg | 1 day | — |
| Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial 2011 · Boswellia group · Patients with primary or secondary malignant cerebral tumors receiving radiotherapy | 4.2 g | — | — |
| Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial 2017 · Herbal Formulation · Adults aged 40–60 with type II diabetes mellitus | 600 mg | 90 days | 30 |
| Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes 2016 · Group 2 (curcumin/BSE group; MD plus Fitomuscle®) · Healthy male master cyclists, mean age 46 ± 8 years, without the listed cardiovascular, metabolic or chronic inflammatory conditions | 140 mg | 12 weeks | 25 |